Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 137 for “"Indoleamine"”.
-
Reactivities of indoleamine 2,3-dioxygenases
The heme enzyme indoleamine 2,3-dioxygenase (IDO1) catalyzes L-Trp oxidation in non-hepatic mammalian tissues by inserting both atoms of dioxygen into the indole ring to form N-formylkynurenine. In the present work, IDO1 was found to oxidize β-NADH under aerobic conditions in the absence of other …
-
Inhibitors of human indoleamine 2,3-dioxygenas
Indoleamine 2,3-dioxygenase (IDO) is a tryptophan degradation enzyme that is emerging as an important drug target. IDO is expressed by many human tumors and results in suppression of the T-cell based immune response. IDO has also been implicated in depression and in the formation of senile nuclear …
-
Dendrimer-Based Proteosomal Degradation of Indoleamine 2,3-Dioxygenase 1(IDO1)
Neuroinflammation is an inflammation response in brain or spinal cord. It plays a key role in pathology of most central nervous system diseases such as Alzheimer’s, Stroke, Multiple Sclerosis, Autism, Traumatic Brain Injury, Gliomas. Therapeutics for neurological disorders take 35% longer to …
-
Inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) for cancer therapy
… of cancer. A tryptophan-catabolising enzyme indoleamine 2,3-dioxygenase-1 (IDO1) is a dominant immune escape mechanism in a broad range of human tumours and its expression is associated with a poor prognosis in cancer. Blockade of IDO1 by small-molecule inhibitors is a validated cancer …
-
Structure guided discovery of inhibitors of indoleamine 2,3-dioxygenase (IDO1)
The enzyme indoleamine 2,3‐dioxygenase‐1 (IDO1) plays a critical role in the regulation of the immune system. IDO1 expression is commonly upregulated in cancer, resulting in a suppressed immune system in patients. Clinical observations that patients with high IDO1‐expressing tumours have a poor …
-
Investigating the role of Indoleamine 2,3 dioxygenase in Huntington disease
… striatal-enriched genes. One identified gene was Indoleamine 2,3 dioxygenase (Ido1), the first and the rate-limiting enzyme of the kynurenine pathway (KP), which was differentially expressed in the striatum of YAC128 mouse model of HD. KP leads to the production of both neuroprotective and …
-
Redox Reactions of the Immune-regulatory Enzyme Indoleamine 2,3-dioxygenase
Indoleamine 2,3-dioxygenase (IDO) is an important immunoregulatory heme enzyme that controls T-cell responses during diverse disease conditions by catalyzing tryptophan degradation along the kynurenine pathway. IDO is expressed within inflammatory or hypoxic tissues, characterized by oxidative …
-
Characterization of indoleamine 2, 3 - dioxygenase activity in breast cancer cells
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
-
Design and Synthesis of Hydroxylamine Derivatives as Indoleamine - 2,3 - Dioxygenase Inhibitors
Current research describing therole of indoleamine 2,3-dioxygenase (IDO) and its mechanism of action suggests that the inhibition of IDO with small molecule inhibitors, especially in conjunction with chemotherapy, can provide an effective and novel cancer treatment strategy. This inspired our …
-
Mechanisms of selective immunosuppressive effects of indoleamine 2, 3-dioxygenase and borrelidin
Indoleamine 2, 3-dioxygenase (IDO), a tryptophan degrading enzyme, is a potent immunomodulatory factor that has been considered as a promising candidate in down-regulating alloimmune responses. IDO expression generates a tryptophan-deficient environment that selectively induces apoptosis in immune …
-
Verification of microbial ethanol formation in humans by examination of postmortem indoleamine metabolites.
Toxicological examination of fatal aviation accident victims routinely includes analysis of ethanol levels. Two distinct questions immediately arise when considering such analyses. The first is, can we stop ethanol production immediately upon receipt of specimens. Previous research suggests such …
-
The Novel Role of Indoleamine 2,3-Dioxygenase (IDO1) in Supporting Long Lived Antibody Responses
… immunosuppressive tryptophan-catabolizing enzyme indoleamine 2,3- dioxygenase 1 (IDO1) expressed in niche dendritic cells (DC) to sustain antigen-specific antibody responses and LLPC survival. Activation of tryptophan catabolism by IDO1 in the LLPC niche is induced by engagement of CD80/CD86 on …
-
Indoleamine 2,3-dioxygenase: a potent regulator of graft versus host disease with potential therapeutic applications.
… be identified. Data presented here establishes indoleamine 2,3-dioxygenase (IDO), an immunosuppressive enzyme in the tryptophan metabolism pathway, as a major regulator of GVHD. IDO-deficient recipients of bone marrow transplant suffered accelerated GVHD lethality, with pathology concentrated in …
-
A Novel Immunomodulatory Approach To Ptoa Mitigation Via Msc-Mediated Expression Of Indoleamine-2,3 Dioxygenase
… one immunomodulatory factor of interest is indoleamine 2,3-dioxygenase (IDO). IDO, a soluble factor secreted by MSCs, is known to play an enzymatic role in the degradation of tryptophan to kynurenines. This reaction has been shown to have a downstream effect on Treg, Th17, and natural killer …
-
Radiosynthesis and preclinical development of [18F]labeled tryptophan for human indoleamine 2,3-dioxygenase PET imaging
… that a novel specific radiotracer of the human indoleamine 2,3-dioxygenase enzyme (hIDO) has been developed during this PhD thesis. This enzyme, highly expressed in numerous human tumors, is also currently subject to the development of various inhibitors. This report presents the development of …
-
Development and application of a non-rejectable islet graft using indoleamine 2,3-dioxygenase (IDO) in diabetes.
… It has been shown that impaired IFNγ-induced indoleamine 2,3-dioxygenase (IDO) expression in dendritic cells of early prediabetic female nonobese diabetic (NOD) mice could contribute to their defective self-tolerance. IDO is an immunomodulatory and rate-limiting enzyme in tryptophan …
Page 1 of 7